The invention provides polypeptides that act both as an agonist of the GLP-1 receptor and an antagonist of the glucagon receptor. Such polypeptides are useful for treating individuals with type 2 diabetes or other metabolic disorders.

 
Web www.patentalert.com

< DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia

> Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
~ 00496